Boosting levels of the neurotransmitter norepinephrine with atomoxetine, a repurposed ADHD medication, may be able to stall neurodegeneration in people with early signs of Alzheimer’s disease, a study conducted at Emory Brain Health Center suggests. The results were published in the journal Brain. Norepinephrine is a neurotransmitter produced mainly by the locus coerueus, part of the...
